LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
28/07/2026
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Snapshot rápido
HEXELECT
ST13
US500000079253307Classe
Pedido
Registro
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Código do desenho
Tipo de titular
Localização do titular
Examinador
Unidade examinadora
Localização atual
Titulares
Representantes
Max Vern AMSTER, ROTHSTEIN & EBENSTEIN LLP
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemical, biochemical, biological, and biotechnological preparations, namely, antibodies, and bi- and multispecific antibodies as well as antibody fragments, monovalent antibodies, and derivatives or conjugates of any of these for in vitro and in vivo scientific and industrial research and development with regard to diseases; active chemical ingredients for use in the manufacture of pharmaceuticals
Classe 5
Pharmaceutical and veterinary preparations, namely, pharmaceutical preparations based on antibodies, and bi- and multispecific antibodies as well as antibody fragments, monovalent antibodies, and derivatives or conjugates of any of these for use with regard to the treatment of cancer, infectious, immune, autoimmune, inflammatory, neurodegenerative and cardiovascular diseases
Classe 42
Medical, scientific and biological research, namely, research into antibodies and bi- and multispecific antibodies as well as antibody fragments, monovalent antibodies, and derivatives or conjugates of any of these and development of pharmaceutical products based on antibodies and bi- and multispecific antibodies or fragments, monovalent antibodies, and derivatives or conjugates of any of these; chemical analysis; computer programming, namely, programming of computers for the collection and processing of medical data in medical scientific research, development and therapy, and scientific research, development and therapy with antibodies and bi- and multispecific antibodies as well as antibody fragments, monovalent antibodies, and derivatives or conjugates of any of these
Classe 45
Legal services in the field of patent exploitation, namely, patent consultation, patent licensing, and providing information about patent rights; licensing of intellectual property in the field of medicine
Histórico de despachos e eventos da marca no USPTO.
41 publicações encontradas
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
28/07/2026
TEAS SECTION 71 RECEIVED
13/06/2026
RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
14/05/2026
RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
05/03/2026
NEW REPRESENTATIVE AT IB RECEIVED
24/04/2025
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
07/01/2025
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
05/06/2024
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/06/2024
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/06/2024
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/06/2024
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/06/2024
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/06/2024
FINAL DECISION TRANSACTION PROCESSED BY IB
08/05/2020
FINAL DISPOSITION NOTICE SENT TO IB
18/04/2020
FINAL DISPOSITION PROCESSED
18/04/2020
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/04/2020
REGISTERED-PRINCIPAL REGISTER
07/01/2020
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
22/10/2019
PUBLISHED FOR OPPOSITION
22/10/2019
NOTIFICATION PROCESSED BY IB
19/10/2019
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/10/2019
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/10/2019
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/10/2019
APPROVED FOR PUB - PRINCIPAL REGISTER
16/09/2019
EXAMINER'S AMENDMENT ENTERED
13/09/2019
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
13/09/2019
EXAMINERS AMENDMENT E-MAILED
13/09/2019
EXAMINERS AMENDMENT -WRITTEN
13/09/2019
TEAS/EMAIL CORRESPONDENCE ENTERED
31/08/2019
CORRESPONDENCE RECEIVED IN LAW OFFICE
31/08/2019
ASSIGNED TO LIE
31/08/2019
TEAS RESPONSE TO OFFICE ACTION RECEIVED
26/08/2019
REFUSAL PROCESSED BY IB
06/04/2019
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
20/03/2019
REFUSAL PROCESSED BY MPU
20/03/2019
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/03/2019
APPLICATION FILING RECEIPT MAILED
09/03/2019
NON-FINAL ACTION WRITTEN
08/03/2019
ASSIGNED TO EXAMINER
05/03/2019
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/03/2019
SN ASSIGNED FOR SECT 66A APPL FROM IB
28/02/2019
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.